Geriatric oncology: A clinical approach to the older patient with cancer

European Journal of Cancer

Volumn 39, Issue 7, 2003, Pages 870-880

  Repetto, L ^a   Venturino, A ^b   Fratino, L ^c   Serraino, D ^d   Troisi, G ^e   Gianni, W ^a   Pietropaolo, M ^e  

^a INRCA   (Italy)

^b UO Oncol Medica USL 1 Imperiese   (Italy)

^c UNIVERSITY HOSPITAL OF PADOVA   (Italy)

^d NATIONAL INSTITUTE FOR INFECTIOUS DISEASES L SPALLANZANI   (Italy)

^e SAPIENZA UNIVERSITY OF ROME   (Italy)

Author keywords

Ageing; Cancer; Comprehensive geriatric assessment; Elderly patients; Geriatric evaluation

Indexed keywords

AGING; ATTITUDE; CANCER PATIENT; CANCER RESEARCH; CANCER RISK; CANCER SURVIVAL; CARCINOMA; CLINICAL PRACTICE; COMORBIDITY; DISABILITY; EMERGENCY TREATMENT; EVALUATION; GERIATRIC CARE; HEALTH STATUS; HUMAN; INFLAMMATION; MENTAL FUNCTION; PHYSICAL DISEASE; POPULATION RESEARCH; PRIORITY JOURNAL; PSYCHOSOCIAL DISORDER; REVIEW;

EID: 0346037296     PISSN: 09598049     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0959-8049(03)00062-5     Document Type: Review

References (123)

1. World Health Statistics Annual. 1987;WHO, Geneva.
2. Murray C.J.L., Lopez Ad. Alternative projections of mortality and disability by cause 1990-2020. global burden of disease study Lancet. 349:1997;1498-1504.
3. Yancik R., Ries L.A.G. Aging and cancer in America. demographic and epidemiologic perspectives Hematol/Oncol Clin, North Am. 14:2000;17-23.
4. Yancik R.M., Ries L. Cancer and age. magnitude of the problem Balducci L., Lyman G.H., Ershler W.B. Comprehensive Geriatric Oncology. 2nd edn:1998;95-103 Harwood Academic, London.
5. Franceschi S., La Vecchia C. Cancer epidemiology in the elderly. Crit. Rev. Oncol. Hematol. 39:2001;219-226.
6. Negri E., La Vecchia C., Decarli A. Cancer mortality in Italy. Tumori. 88:2002;89-94.
7. Parkin D.M., Whelan S.L., Ferlay J., Raymond L., Young J. Cancer Incidence in Five Continents, vol. VII. IARC Sci Publication No. 143. 1997;IARC, Lyon.
8. Armitage P., Doll R. A two-stage theory of carcinogenesis in relation to the age distribution of human cancer. Br. J. Cancer. 11:1961;161-169.
9. Stanta G., Campagner L., Cavallieri F., Giarelli L. Cancer of the oldest old. what we have learned from autopsy studies Clin. Ger. Med. 13:1997;55-68.
10. Peto R, Parish SE, Gray RG. There is no such thing as ageing, and cancer is not related to it. In Likhacev A, Anisimov V, Montesano R, eds. Age-related Factors in Carcinogenesis: Proceedings of a Symposium. Lyon, IARC, 1985, 45-53.
11. Balducci L., Extermann M. Cancer and aging. An evolving panorama. Hematol. Oncol. Clin. North Am. 14:2000;1-16.
12. Vercelli M., Quaglia A., Casella C., Parodi S., Capocaccia R., Martinez Garcia C. Relative survival in elderly cancer patients in Europe. EUROCARE Work Group. Eur. J. Cancer. 34:1998;2264-2270.
13. Balducci L., Lyman G.H. Cancer in the elderly. epidemiologic and clinical implications Clin. Geriatr. Med. 13:1997;1-14.
14. Levi F., Lucchini F., Negri E., Boyle P., La Vecchia C. Changed trends of cancer mortality in the elderly. Ann. Oncol. 12:2001;1467-1477.
15. Begg C.B., Cohen J.L., Ellerton J. Are the elderly predisposed to toxicity from cancer chemotherapy? An investigation using data from the Eastern Cooperative Oncology Group. Clin. Trials. 3:1980;369-374.
16. Kemeny M., Muss H.B., Kornblith A.B., Peterson B., Wheeler J., Cohen H.J. Barriers to participation of older women with breast cancer in clinical trials. Proc. Am. Soc. Clin. Oncol. 19:2000;2371.
17. Maly R.C. Qualitative research for the study of cancer and age. Hematol. Oncol. Clin. North Am. 14:2000;79-88.
18. Schmidt K. Physiology and pathophysiology of senescence. Int. J. Vitam. Nutr. Res. 69:1999;150-153.
19. Glass A.G., Hoover R.N. The emerging epidemics of melanoma and squamous cell skin cancer. J. Am. Med. Ass. 262:1989;2097-2100.
20. Balducci L., Pow-Sang J., Friedland J., Diaz J.I. Prostate cancer. Clin. Ger. Med. 13:1997;283-307.
21. Anisimov V.N., Gvardina O.E. N-Nitrosomethylurea-induced carcinogenesis in the progeny of male rats of different ages. Mutat. Res. 316:1995;139-145.
22. Randerath K., Liehr J.G., Gladeck A., Randerath E. Age-dependent covalent DNA alteration (I compounds) in rodent tissues. species, tissue and sex specifications Mutat. Res. 219:1989;121-133.
23. Collins K. Mammalian telomeres and telomerase. Curr. Opin. Cell Biol. 12:2000;378-383.
24. Liggett W.H., Sidransky D. Role of the P16 tumor suppressor gene in cancer. J. Clin. Oncol. 16:1998;1197-1206.
25. Anisimov V.N. Age as a risk factor in multistage carcinogenesis. Balducci L., Lyman G.H., Ershler W.B. Comprehensive Geriatric Oncology. 1998;157-178 Harwood Academic, Amsterdam.
26. Kraupp-Grasl B., Huber W., Taper H., Schulte-Hermann R. Increased susceptibility of aged rats to hepatocarcinogenesis induced by the peroxisome proliferator nafenopin and the possible involvement of altered liver foci occuring spontaneously. Cancer Res. 51:1991;666-671.
27. Ebbesen P. Papilloma development on young and senescent mouse skin treated with 12-tetradecanoylforbol-13-acetate. Likhacev A., Anisimov V., Montesano R.et al. Age-related Factors in Carcinogenesis. IARC Scientific Publication No. 58. 1985;167-170 IARC, Lyon, France.
28. Barbone F., Bovenzi M., Cavallieri F., Stanta G. Air pollution and lung cancer in Trieste, Italy. Am. J. Epidemiol. 141:1995;1161-1169.
29. Monfardini S., Carbone A. Non-Hodgkin's lymphomas. Balducci L., Lyman G.H., Ershler W.B. Comprehensive Geriatric Oncology. 1998;577-595 Harwood Academic, Amsterdam.
30. Flowers A. Brain tumors. Balducci L., Lyman G.H., Ershler W.B. Comprehensive Geriatric Oncology. 1998;703-720 Harwood Academic, Amsterdam.
31. Balducci L. Geriatric Oncology. challenges for the new century Eur. J. Cancer. 36:2000;1741-1754.
32. Goodwin J., Burns E. Immunological changes of aging. Balducci L., Lyman G.H., Ershler W.B. Comprehensive Geriatric Oncology. 1998;213-222 Harwood Academic, Amsterdam.
33. Bonafè M., Valesin S., Gianni W., Marigliano W., Franceschi C. The unexpected contribution of immunosenescence to the levelling off of cancer incidence and mortality in the oldest old. Crit. Rev. Oncol. Hematol. 39:2001;227-233.
34. Campisi J. Cancer and age. the double sword of proliferative senescence J. Am. Ger. Soc. 45:1997;482-488.
35. Warner H.R. Aging and regulation of apoptosis. Curr. Top. Cell Regul. 35:1997;107-121.
36. Franceschi C., Monti D., Sansoni P., Cossarizza A. The immunology of exceptional individuals. the lesson of centenarians Immunol. Today. 16:1995;12-16.
37. Lancet J.E., Willman C.L., Bennett J.M. Acute myelogenous leukemia and aging. clinical interactions Hematol. Oncol. Clinics. North Am. 16:2000;251-268.
38. The International Non-Hodgkin's Lymphoma prognostic factors project: a predictive model for aggressive non-hodgkin's lymphoma. N Engl J Med 1993, 329, 87-94.
39. Thigpen J.T. Gynecologic cancer. Balducci L., Lyman G.H., Ershler W.B. Comprehensive Geriatric Oncology. 1998;721-732 Harwood Academic, Amsterdam.
40. Ershler W.B. Tumor-host interactions, aging and tumor growth. Balducci L., Lyman G.H., Ershler W.B. Comprehensive Geriatric Oncology. 1998;201-211 Harwood Academic, Amsterdam.
41. Willman C.L. The prognostic significance of the expression and function of multidrug resistance transporter proteins in acute myeloid leukaemia. studies of the Southwest Oncology Group Leukemia Research programm Semin. Hematol. 34:1997;25-36.
42. Hamermann D., Berman J.W., Albers G.W., Brown D.L., Silver D. Emerging evidence for inflammation in conditions frequently affecting older adults. report of a symposium J. Am. Ger. Soc. 47:1999;995-999.
43. Preti H.J., Cabanillas F., Talpaz M., Jucker S.L., Seymour J.F., Kurzrock R. Prognostic value of serum interleukin-6 in diffuse large cell lymphoma. Ann. Intern. Med. 127:1997;186-194.
44. Balducci L, Silliman RA, Diaz N. Breast cancer: an oncological perspective. In Balducci L, Lyman GH, Ershler WB, eds. Comprehensive Geriatric Oncology, 2nd ed. London, Harwood Academic (in press).
45. Hamermann D. Toward an understanding of frailty. Ann. Intern. Med. 130:1999;945-950.
46. Cohen H.J., Pieper C.F., Harris T. Markers of inflammation and coagulation predict decline in function and mortality in community dwelling elderly. Proc. Am. Ger. Soc. S1:2001;. (abstr A3).
47. Bruunsgaard H., Pedersen M., Pedersen B.K. Aging and proinflammatory cytokines. Curr. Opin. Hematol. 8:2001;131-136.
48. Kushner I. C-reactive protein elevation can be caused by conditions other than inflammation and may reflect biologic aging. Cleve. Clin. J. Med. 68:2001;535-537.
49. Taaffe D.R., Harris T.B., Ferrucci L., Rowe J., Seeman T.E. Cross-sectional and prospective relationships of interleukin-6 and C-reactive protein with physical performance in elderly persons. MacArthur studies of successful aging J. Gerontol. A Biol. Sci. Med. Sci. 55:2000;M709-M715.
50. Balducci L. The comprehensive geriatric assessment in the management of the older person with cancer. Eur J Gerontol (in press).
51. Craig Rubin D., Sizemore T., Loftis P.A., Loret de Nola N. A randomized, controlled trial of outpatient geriatric evaluation and management in a large public hospital. J. Am. Ger. Soc. 41:1993;1023-1028.
52. Stuck A.E., Aronow H.U., Steiner A.et al. A trial of annual in-home comprehensive geriatric assessment for elderly people living in the community. N. Engl. J. Med. 333:1995;1184-1189.
53. Christensen K. Why do we age so differently? Lakartidningen. 96:1999;5099-5102.
54. Fratiglioni L., Von Strauss E., Winblad B. Epidemiology of aging with focus on physical and mental functional ability. Lakartidningen. 98:2001;552-558.
55. MacKnight C., Rockwood K. Use of chronic disease score to measure comorbidity in the Canadian Study of Health and Aging. Int. Psychogeriatr. 13:2001;37-142.
56. Charlson M.E., Pompei P., Ales K., Mackenzie C.R. A new method of classifying comorbidity in longitudinal studies. development and validation J. Chronic. Dis. 40:1987;373-383.
57. Miller M.D., Paradis C.F., Houck P.R.et al. Rating chronic medical illness burden in geropsychiatric practice and research. application of the cumulative illness rating scale Psychiatric. Res. 41:1992;237-248.
58. Nikolaus T. Effect of physical activity on functional performance. Z. Gerontol. Geriatr. 34:2001;44-47.
59. Leveille S.G., Guralnik J.M., Ferrucci L., Langlois J.A. Aging successfully until death in old age. opportunities for increasing active life expectancy Am. J. Epidemiol. 149:1999;654-664.
60. Pientka L. Knowledge for prolonging longevity without disability. Z. Gerontol. Geriatr. 34:2001;38-43.
61. Dartigues J.F., Fabrigoule C., Barberger-Gateau P., Orgogozo J.M. emory, aging and risk factors. Lessons from clinical trials and epidemiologic studies. Therapie. 55:2000;503-505.
62. Unger J.B., McAvay G., Bruce M.L., Berkman L., Seeman T. Variation in the impact of social network characteristics on physical functioning in elderly persons. MacArthur Studies of Successful Aging J. Gerontol. B Psychol. Sci. Soc. Sci. 54:1999;S245-S251.
63. Weitzner M.A., Haley W.E., Chen H. The family caregiver of the older cancer patient. Hematol. Oncol. Clin. 14:2000;269-282.
64. Haley W.E., Ehrbar L., Schonwetter R.S. Family caregiving issues. Balducci L., Lyman G.H., Ershler W.B. Comprehensive Geriatric Oncology. 1998;805-812 Harwood Academic, London.
65. Hayman J.A., Langa K.M., Kabeto M.U.et al. Estimating the cost of informal caregiving for elderly patients with cancer. J. Clin. Oncol. 19:2001;3219-3225.
66. Balducci L., Extermann M. A practical approach to the older patient with cancer. Current problems. Cancer. 25:2001;1-76.
67. Guigoz Y, Vellas B, Garry PJ. Mininutritional assessment: a practical assessment tool for grading the nutritional state of elderly patients. In Guigoz Y, Vellas B, Garry PJ, eds. Facts, Research, Interventions in Geriatrics, 1997. New York, Serdi, 1997, 15-60.
68. Corcoran M.B. Polypharmacy in the older patient. Balducci L., Lyman G.H., Ershler W.B. Comprehensive Geriatric Oncology. 1998;525-532 Harwood Academic, London.
69. Meydani M. Nutrition interventions in aging and age-associated disease. Ann. N. Y. Acad. Sci. 928:2001;226-235.
70. Fox R.A., Pxty J. Geriatric and the Problem Solving Approach. Medicine in the Frail Elderly: A Problem Oriented Approach. 1993;Arnold, London. 1-13.
71. Guralnik JM, LaCroix AZ, Everett DF, Kovar MG. Aging in the Eighties: The Prevalence of Comorbidity and Its Association with Disability. Advance Data from Vital and Health Statistical 1989, No. 170. National Center of Health Statistic, Bethesda, USA.
72. Katz S., Downs T.D., Cash H.R., Grotz R.C. Progress in development of the index of ADL. Gerontologist. 10:1970;20-30.
73. Lawton M.P., Brody E. Assessment of older people. self-maintaining and instrumental activities of daily living Gerontologist. 9:1969;179-186.
74. Fratino L., Ferrario L., Redmond K., Audisio R.A. Global Health care. the role of geriatrician, general practitioner and oncology nurse Crit. Rev. Oncol. Hematol. 27:1998;101-109.
75. Matthews D.A. Marjory Warren and the origin of British geriatrics. J. Am. Geriatr. Soc. 32:1984;253-258.
76. Hendriksen C., Lund E., Stremgard E. Consequences of assessment and intervention among elderly people. a 3 year randomised controlled trial Br. Med. J. 289:1984;1522-1524.
77. Stuck A.K., Siu A.L., Wieland D.G., Adams J., Rubenstein L.Z. Comprehensive geriatric assessment. A meta-analysis of controlled trials. Lancet. 342:1993;1032-1036.
78. Standardised Assessment Scales for Elderly People. 1992;Royal College of Physicians, London.
79. American College of Physicians. Comprehensive geriatric assessment for elderly patients. position paper. Ann. Intern. Med. 1:1988;70-73.
80. Applegate W.B., Miller S.T., Graney M.J., Elam J.T., Burns R., Akins D.E. A randomised controlled trial of geriatric assessment unit in a community rehabilitation hospital. New Engl. J. Med. 322:1990;1572-1578.
81. Bernabei R., Landi F., Gambassi G.et al. Randomised trial of impact of model of integrated care and case management for older people living in the community. Br. Med. J. 316:1998;1348-1351.
82. Alessi C.A., Stuck A.E., Aronow H.U.et al. The process of care in preventive "in home" comprehensive geriatric assessment. J. Am. Ger. Soc. 45:1997;1044-1050.
83. Tinetti M.E., Baker D.I., McAvay G., Claus E.B., Garret P., Gottschalk M. A multifactorial intervention to reduce the risk of falling among elderly people living in the community. N. Engl. J. Med. 331:1994;821-827.
84. Inouye S.K., Bogardus S.T., Charpentier P.A.et al. A multicomponent intervention to prevent delirium in hospitalized older patients. N. Engl. J. Med. 340:1999;669-676.
85. Reuben D.B., Franck J.C., Hirsch S.H., McGuigan K.A., Maly R.C. A randomized clinical trial of outpatient geriatric assessment (CGA), coupled with an intervention, to increase adherence to recommendations. J. Am. Ger. Soc. 47:1999;269-276.
86. Fried L.P., Walston J. Frailty and failure to thrive. Hazzard W.R., Blass J.P., Ettinger W.H., Halter J.B., Ouslander J.G. Principle of Geriatric Medicine and Gerontology. 4th ed. 1999;1387-1402 McGraw Hill, New York.
87. Rockwood K., Fox R.A., Stolee P. Frailty in elderly people. an evolving concept Can. Med. Assoc. J. 150:1994;489-495.
88. Campbell A.J., Buchner D.M. Unstable disability and the fluctuations of frailty. Age Ageing. 26:1997;315-318.
89. Ferrucci L., Harris T.B., Guralnik J.M.et al. Serum IL-6 and the development of disability in older persons. J. Am. Geriatr. Soc. 47:1999;639-646.
90. Wallace D.C. Mitochondrial diseases in man and mouse. Science. 283:1999;1482-1488.
91. Morley J.E., Kaiser F.E., Sih R., Hajjar R., Perry 3rd H.M. Testosterone and frailty. Clin. Geriatr. Med. 13:1997;685-695.
92. Ranieri P., Rozzini R., Franzoni S., Barbisoni P., Trabucchi M. Serum cholesterol levels as measure of frailty in elderly patients. Exp. Aging Res. 24:1998;169-179.
93. Fried L.P., Tangen C., Walston J.et al. Frailty on older adults. evidence for a phenotype J. Gerontol. Med. Sci. 56:2001;M146-M156.
94. Rockwood K., Stadnyk K., Macknight C., McDowell I., Hebert R., Hogan D.B. A brief clinical instrument to classify frailty in elderly people. Lancet. 353:1999;205-206.
95. Balducci L., Stanta G. Cancer in the frail patient. a coming epidemic Hematol. Oncol. Clin. North Am. 14:2000;235-250.
96. Repetto L., Comandini D. Cancer in the elderly. assessing patients for fitness Crit. Rev. Oncol. Hematol. 35:2000;155-160.
97. Exterman M., Aapro M. Assessment of the older cancer patient. Hematol. Oncol. Clin. North Am. 14:2000;63-77.
98. Monfardini S., Ferrucci L., Fratino L., Del Lungo I., Serraino D., Zagonel V. Validation of a multidimensional evaluation scale for use in elderly cancer patients. Cancer. 77:1996;395-401.
99. Repetto L., Fratino L., Audisio R.A.et al. The Comprehensive Geriatric Assessment adds information to ECOG Performance Status in elderly cancer patients. a GIOGer study J. Clin. Oncol. 20:2002;494-502.
100. Bennet J.M., Sahasrabudhe D.M., Hall W.J. Medical oncology and geriatric medicine it is time to fellowship integration. Ann. Oncol. 9:1998;S16-S18.
101. Balducci L., Beghè C. The application of the principles of geriatrics to the management of the older person with cancer. Crit. Rev. Oncol. Hematol. 35:2000;147-154.
102. Reuben D.B., Rubenstein L.V., Hirsch S.H., Hays R.D. Value of functional status as predictor of mortality. Am. J. Med. 93:1992;663-669.
103. Inoyue S.K., Peduzzi P.N., Robison J.T., Hughes J.S., Horwitz R.I., Concato J. Importance of functional measures in predicting mortality among older hospitalized patients. JAMA. 279:1998;1187-1193.
104. Siu A.L., Moshita L., Blaustein J. Comprehensive geriatric assessment in a day hospital. J. Am. Ger. Soc. 42:1994;1094-1099.
105. Barbeger-Gateau P., Fabrigoule C., Helmer C., Rouch I., Dartigues J.F. Functional impairment in instrumental activities of daily living. an early clinical sign of dementia? J. Am. Ger. Soc. 47:1999;456-462.
106. Satariano W.A., Ragland D.R. The effect of comorbidity on 3-year survival of women with primary breast cancer. Ann. Int. Med. 120:1994;104-110.
107. Piccirillo J.F., Feinstein A.R. Clinical symptoms and comorbidity. significance for the prognostic classification of cancer Cancer. 77:1996;834-842.
108. Manton K. A longitudinal study of functional change and mortality in the United States. J. Gerontol. 43:1988;S153-S161.
109. Eagles J.M., Beattie J.A.G., Restall D.B., Rawlinson F., Hagen S., Ashcroft G.W. Relationship between cognitive impairment and early death in the elderly. Br. Med. J. 300:1990;239-240.
110. Bruce M.L., Hoff R.A., Jacobs S.C., Leaf P.J. The effect of cognitive impairment on 9-year mortality in a community sample. J. Gerontol. 50:1995;P289-P296.
111. Folstein M.E., Folstein S.E., McHugh P.R. A mini mental state. a practical method for grading the cognitive status of patients for the clinician J. Psychiatr. Res. 12:1975;189-198.
112. Covinsky K.E., Kahana E., Chin M.H., Palmer R.M., Fortinsky R.H., Landefeld C.S. Depressive symptoms and three year mortality in older hospitalized medical patients. Ann. Int. Med. 130:1999;563-569.
113. Lyness J.M., King D.A., Cox C., Yoedino Z., Caine E.D. The importance of subsyndromal depression in older primary care patients. Prevalence and associated functional disability. J. Am. Ger. Soc. 47:1999;647-652.
114. Kimmick G.G., Muss H.B. Systemic therapy for older women with breast cancer. Oncology (Huntingt.). 15:2001;280-291. [discussion 291-292, 295-296, 299].
115. Repetto L., Venturino A., Vercelli M.et al. Performance status and comorbidity in elderly cancer patients compared to a young neoplastic and an elderly non-neoplastic population. Cancer. 82:1998;760-765.
116. Satoh H., Ishikawa H., Funayama Y.et al. Management of small cell lung cancer in elderly. Anticancer Res. 19:1999;4507-4510.
117. Ashkanani F., Eremin O., Heys S.D. The management of cancer of the breast in the elderly. Eur. J. Surg. Oncol. 24:1998;396-402.
118. Muss H.B. Breast cancer in older women. Semin. Oncol. 23(Suppl. 2):1996;S82-S88.
119. Kennedy B.J. Cancer research and the aging population. Oncol. Issues. 15:2000;20-28.
120. Goodwin J.S., Hunt W.C., Samet J.M. Determinants of cancer therapy in elderly patients. Cancer. 72:1993;594-601.
121. Goodwin J.S., Samet J.M., Key C.R., Humble C., Kutvirt D., Hunt C. Stage at diagnosis of cancer varies with the age of the patient. J. Am. Geriatr. Soc. 34:1986;20-26.
122. Johnson D.H. Small cell lung cancer in the elderly patient. Semin. Oncol. 24:1997;484-491.
123. Monfardini S., Sorio R., Kaye S. Should elderly cancer patients be entered in dose-escalation studies? Ann. Oncol. 5:1994;964-966.